3,234 results on '"Pheochromocytoma"'
Search Results
2. The Role of Active Brown Adipose Tissue in Patients With Pheochromocytoma or Paraganglioma
3. The role of cell cycle-related genes in the tumorigenesis of adrenal and thyroid neuroendocrine tumors
4. Update on the diagnosis of the pheochromocytoma
5. Systemic therapy for patients with metastatic pheochromocytoma and paraganglioma
6. Clinical presentation of pheochromocytoma and screening recommendations
7. Paragangliome et grossesse : une histoire mictionnelle palpitante
8. Progress in surgical approaches and outcomes of patients with pheochromocytoma and paraganglioma
9. Role of B cells in intratumoral MBTA immunotherapy of murine pheochromocytoma model
10. The current and upcoming era of radiomics in phaeochromocytoma and paraganglioma
11. Recent progress in the pathologic classification of pheochromocytomas and paragangliomas
12. Update on clinical characteristics in the evaluation of phaeochromocytoma and paraganglioma
13. MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma
14. Recent discoveries of Sino-Caucasian differences in the genetics of phaeochromocytomas and paragangliomas
15. Pre-clinical phaeochromocytoma and paraganglioma models: Cell lines, animal models, and a human primary culture model
16. Clinical and molecular markers guide the genetics of pheochromocytoma and paraganglioma
17. TMEM-127 gene mutation: A rare genetic entity associated with metastatic bilateral pheochromocytoma
18. Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy
19. [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
20. 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
21. Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors (212-Pb]-VMT)
22. Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer
23. Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
24. Diagnosis of Pheochromocytoma
25. 18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System
26. Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
27. Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
28. Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
29. Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
30. Ivocizumab in the Treatment of Multiple Advanced Tumors
31. The Registry of Oncology Outcomes Associated with Testing and Treatment (ROOT)
32. Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
33. 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma
34. Management of Hereditary Syndromes Associated with Pheochromocytoma/Paraganglioma
35. Adrenal Incidentaloma
36. Imaging in Adrenocortical Carcinoma and Malignant Pheochromocytoma
37. Genetics and Molecular Biology of Pheochromocytoma and Paraganglioma
38. Epidemiology, Presentation, Staging, and Prognostic Factors in Malignant Pheochromocytoma
39. Medical Treatment of Malignant Pheochromocytoma
40. Role of Radiotherapy in Adrenocortical Carcinoma and Pheochromocytoma
41. Radionuclide Treatment in Malignant Pheochromocytoma
42. Preclinic and Translational Research in Adrenal Malignancies
43. Pathology of Adrenocortical Carcinoma and Malignant Pheochromocytoma
44. Surgery for Malignant Pheochromocytoma
45. HTL0039732 in Participants with Advanced Solid Tumours
46. Hereditary Pheochromocytoma Assessment of Tumour Immunologies (HEPHESTOS)
47. Cabozantinib S-malate in Treating Patients with Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery
48. A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma (Spencer)
49. Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs
50. DOTATOC PET/CT for Imaging NET Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.